69042
Strontium chloride solution
0.1 M
Synonym(s):
Additive Screening Solution 27/Kit-No 78374
Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
CAS Number:
NACRES:
NA.32
PubChem Substance ID:
UNSPSC Code:
12352302
MDL number:
Form:
liquid
Product Name
Strontium chloride solution, 0.1 M
InChI key
CIOAGBVUUVVLOB-UHFFFAOYSA-N
SMILES string
[Sr]
InChI
1S/Sr
form
liquid
concentration
0.1 M
density
1.01 g/mL at 20 °C
storage temp.
2-8°C
Quality Level
Looking for similar products? Visit Product Comparison Guide
General description
Strontium chloride solution is an additive screening solution of Additive Screening Kit. Additive Screen kit is designed to allow rapid and convenient evaluation of additives and their ability to influence the crystallization of the sample. The Additive Kit provides a tool for refining crystallization conditions.
signalword
Warning
hcodes
Hazard Classifications
Eye Irrit. 2
Storage Class
12 - Non Combustible Liquids
wgk
nwg
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Gang Liu et al.
Theriogenology, 113, 78-84 (2018-02-24)
The survival rate of vitrified-thawed ovarian tissues after autotransplantation still needs to be improved. Therefore finding an ideal cryoprectant to reduce the damage to ovaries that caused by vitrification will pave the way for application of ovary cryopreservation on clinics.
Diane Cummins
American journal of dentistry, 23 Spec No A, 3A-13A (2011-02-03)
To provide a brief overview of the diagnosis, epidemiology, etiology and clinical management of dentin hypersensitivity, to discuss technical approaches to relieve sensitivity, with special emphasis on dentin tubule occlusion and the clinical evidence for efficacy of desensitizing toothpastes based
Tetsuya Taguchi
Clinical calcium, 21(3), 429-438 (2011-03-02)
In metastatic breast cancer the most common metastatic site is bone. Skeletal-related events (SREs) as well as bone pain are well-known characteristics of bone metastasis. Activation of osteoclast is the most important mechanism for the progression of bone metastasis. To
Serdal Kirmizialtin et al.
Biophysical journal, 102(4), 829-838 (2012-03-06)
The distributions of different cations around A-RNA are computed by Poisson-Boltzmann (PB) equation and replica exchange molecular dynamics (MD). Both the nonlinear PB and size-modified PB theories are considered. The number of ions bound to A-RNA, which can be measured
Karen A Autio et al.
Current treatment options in oncology, 13(2), 174-188 (2012-04-25)
Skeletal metastases threaten quality of life, functionality, and longevity in patients with metastatic castration-resistant prostate cancer (mCRPC). Therapeutic strategies for bone metastases in prostate cancer can palliate pain, delay/prevent skeletal complications, and prolong survival. Pharmacologic agents representing several drug classes
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service